This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

There are many possible explanations for that, including side effects and the drug’s cost. According to a KFF analysis, the list price for GLP-1 drugs can range between $936 and $1,349 before ...

Wegovy (semaglutide) has a list price of $1,349.02 for a four ... Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling the cheaper, generic version of a drug ...

Medifast is leveraging the transformative potential of GLP-1 medications, which are reshaping ... You can see the complete list of today’s Zacks #1 Rank stocks here. The consensus estimate ...

The full list of key “news-flow” events in 2025 ... That asset could be one of the three GLP-1 agonist drugs Roche is guiding through clinical studies, that it acquired via is $2.7bn ...

It's possible that Alzheimer's disease could be added to the lengthening list of ... injectable GLP-1 agonist liraglutide in people with early-stage Alzheimer's has shown that the drug was able ...

The results come just a few weeks after a once-weekly injectable GLP-1 drug CT-388 – also sourced ... one of a lengthening list of pharma companies that are hoping to hit on effective 'me ...